Plk1 plays an important role in the multiple aspects of the cell cycle and is overexpressed in tumors, thereby making the Plk1 an attractive target for cancer therapeutics (Iliaki et al. 2021; Kressin et al. 2021; Zhang et al. 2021). The gene discussed is PLK1; the disease is cancer.